SEC Form 4

FORM 4		UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940	OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5
	Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person* Fife John M. (Last) (First) (Middle) 303 EAST WACKER DRIVE, SUITE 311 (Street) CHICAGO IL 60601 (City) (State) (Zip)	2. Issuer Name and Ticker or Trading Symbol UNITED AMERICAN HEALTHCARE CORP [ UAHC ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director X 10% Owner Officer (give title below) Other (specify below)
	3. Date of Earliest Transaction (Month/Day/Year) 12/15/2009
	4. If Amendment, Date of Original Filed (Month/Day/Year)	6. Individual or Joint/Group Filing (Check Applicable Line) Form filed by One Reporting Person X Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/15/2009		P		20,100	A	$1	1,068,083	I	By Iliad Research and Trading, L.P.
Common Stock	12/28/2009		P		99	A	$0.98	1,068,182	I	By Iliad Research and Trading, L.P.
Common Stock	12/29/2009		P		300	A	$0.98	1,068,482	I	By Iliad Research and Trading, L.P.
Common Stock	12/29/2009		P		10,223	A	$1.0249	1,078,705	D
Common Stock	12/30/2009		P		112,200	A	$1.0498	1,190,905	I	By Iliad Research and Trading, L.P.
Common Stock	12/31/2009		P		500	A	$1.05	1,191,405	I	By Iliad Research and Trading, L.P.
Common Stock	12/31/2009		P		2,900	A	$1.0469	1,194,305	D
Common Stock	01/04/2010		P		2,498	A	$1.0128	1,196,803	I	By Iliad Research and Trading, L.P.
Common Stock	01/06/2010		P		15,630	A	$0.997	1,212,433	I	By Iliad Research and Trading, L.P.
Common Stock	01/07/2010		P		17,800	A	$0.9972	1,230,233	I	By Iliad Research and Trading, L.P.
Common Stock	01/08/2010		P		5,300	A	$1.02	1,235,533	I	By Iliad Research and Trading, L.P.
Common Stock	01/08/2010		P		10,910	A	$1.017	1,246,443	I	By Iliad Research and Trading, L.P.
Common Stock	01/11/2010		P		15,510	A	$1.03	1,261,953	I	By Iliad Research and Trading, L.P.
Common Stock	01/12/2010		P		2,500	A	$1.04	1,264,453	I	By Iliad Research and Trading, L.P.
Common Stock	01/13/2010		P		7,420	A	$1.033	1,271,873	I	By Iliad Research and Trading, L.P.

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

1. Name and Address of Reporting Person* Fife John M. (Last) (First) (Middle) 303 EAST WACKER DRIVE, SUITE 311 (Street) CHICAGO IL 60601 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Iliad Research & Trading, L.P. (Last) (First) (Middle) 303 EAST WACKER DRIVE (Street) CHICAGO IL 60601 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Iliad Management, LLC (Last) (First) (Middle) 303 EAST WACKER DRIVE (Street) CHICAGO IL 60601 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

1. Name and Address of Reporting Person* Fife Trading, Inc. (Last) (First) (Middle) 303 EAST WACKER DRIVE (Street) CHICAGO IL 60601 (City) (State) (Zip) Relationship of Reporting Person(s) to Issuer Director X 10% Owner Officer (give title below) Other (specify below)

Explanation of Responses:

Remarks:

Form 2 of 3

	/s/ John M. Fife	03/19/2010
	/s/ John M. Fife, Authorized Signatory, Fife Trading, Inc., its manager, Iliad Management, LLC, its general partner for Iliad Research and Trading, L.P.	03/19/2010
	/s/ John M. Fife, Authorized Signatory, Fife Trading, Inc., its manager for Iliad Management, LLC	03/19/2010
	/s/ John M. Fife, Authorized Signatory for Fife Trading, Inc.	03/19/2010
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.